Catherine Fleener

Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation

Robert Latek, Catherine Fleener, Vahideh Lamian et al. · Transplantation · 2009 · 101 citations

Life Sciences, Immunology, Pharmacology +13

2019 White Paper on Recent Issues in Bioanalysis: FDA Immunogenicity Guidance, Gene Therapy, Critical Reagents, Biomarkers and Flow Cytometry Validation (Part 3 – Recommendations on 2019 FDA Immunogenicity Guidance, Gene Therapy Bioanalytical Challenges, Strategies for Critical Reagent Management, Biomarker Assay Validation, Flow Cytometry Validation & CLSI H62)

Steven P. Piccoli, Devangi Mehta, Alessandra Vitaliti et al. · Bioanalysis · 2019 · 95 citations · Full text

Pharmacy, Biomedical Sciences, Biopharmaceutics +13

A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety

Suzanne J. Suchard, Patricia M. Davis, Selena Kansal et al. · The Journal of Immunology · 2013 · 57 citations

Life Sciences, Immunology, Pharmacology +17

Acridone-Based Inhibitors of Inosine 5‘-Monophosphate Dehydrogenase:  Discovery and SAR Leading to the Identification of <i>N</i>-(2-(6-(4-Ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419)

Scott H. Watterson, Ping Chen, Yufen Zhao et al. · Journal of Medicinal Chemistry · 2007 · 49 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Development of a Binding Assay for p53/HDM2 by Using Homogeneous Time-Resolved Fluorescence

Stefanie A. Kane, Catherine Fleener, Yun Zhang et al. · Analytical Biochemistry · 2000 · 45 citations

Medicine, Molecular Biology, Oncology +13